A technique for encapsulating the anti-inflammatory dodecapeptide ingramon into microspheres of a biodegradable copolymer of lactic and glycolic acids (PLGA) to provide prolonged release of the peptide for up to 28 d is presented. The technique makes it possible to achieve >90% encapsulation efficiency and is suitable for producing an injectable suspension that meets the requirements of the State Pharmacopoeia of the Russian Federation. The peptide distribution inside the obtained microspheres and its release kinetics were characterized. A tendency toward suppression of JE/CCL2-dependent monocyte migration was revealed in mice with preliminary (7 d before the experiment) administration of ingramon-depot.
Similar content being viewed by others
References
M. Xia and Z. Sui, Expert Opin. Ther. Pat., 19(3), 295 – 303(2009); doi: https://doi.org/10.1517/13543770902755129; PMID: 19441905.
E. I. Chazov, T. L. Krasnikova, Zh. D. Bespalova, et al., Dokl. Akad. Nauk, 411, 1 – 3 (2006).
T. L. Krasnikova, P. I. Nikitin, T. I. Ksenevich, et al., Biol. Membr., 28(1), 68 – 76 (2011).
T. I. Arefieva, T. L. Krasnikova, A. V. Potekhina, et al., Inflammation Res., 60(10), 955 – 964 (2011).
A. Butreddy, R. P. Gaddam, N. Kommineni, et al., Int. J. Mol. Sci., 22(16), 8884 (2021); doi: https://doi.org/10.3390/ijms22168884.
A. G. Ding and S. P. Schwendeman, Pharm. Res., 25(9), 2041 – 2052 (2008).
M. V. Sidorova, U. S. Dudkina, D. V. Avdeev, et al., Bioorg. Khim., 46(4), 385 – 395 (2020); doi: https://doi.org/10.31857/S0132342320040272.
S. Ren, C. Wang, L. Guo, et al., Nanomaterials (Basel), 11(7), 1758 (2021); doi:https://doi.org/10.3390/nano11071758.
State Pharmacopoeia of the RF, XIVth Ed., Vol. 1, GPM. 1.4.2.0014.15 “Dissolution for solid dosage forms” [in Russian]; http://femb.ru/femb/pharmacopea.php.
H. Jin, H. Chong, Y. Zhu, et al., Eng. Life Sci., 20(11), 476 – 484 (2020).
I. D. Rosca, F. Watari, and M. Uo, J. Controlled Release, 99(2), 271 – 280 (2004).
A. M. Sophocleous, Y. Zhang, and S. P. Schwendemana, J. Controlled Release, 137(3), 179 – 184 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 8, pp. 59 – 66, August, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Marmiy, N.V., Arefieva, T.I., Esipov, D.S. et al. Biodegradable Microparticles with Encapsulated Anti-Inflammatory Peptide Ingramon. Pharm Chem J 57, 1290–1297 (2023). https://doi.org/10.1007/s11094-024-03037-w
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-024-03037-w